Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors

: The role of stereotactic body radiation therapy (SBRT) in the management of advanced EGFR/ALK/ROS1-driven non-small cell lung carcinoma (NSCLC) remains undefined. In EGFR-mutant NSCLC, 50-60% of recurrences on first-line tyrosine kinase inhibitor (TKI) occur in originally involved sites and may le...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of radiation oncology, biology, physics biology, physics, 2024-11
Hauptverfasser:	Keane, Florence K., Yeap, Beow Y., Khandekar, Melin J., Lin, Jessica J., Dagogo-Jack, Ibiayi, Sequist, Lecia V., Piotrowska, Zofia, Willers, Henning
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!